Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

gp96 suppresses PRRSV replication via its C-terminal domain and IRF3/NF-κB signaling.

Created on 15 Nov 2026

Authors

Mao Cai, Chao Li, Xin Wang, Haotian Li, Yaru Yuan, Junpeng Zhao, Yunlong Li, Xiaoya Ding, Aijun Sun, Angke Zhang, Bo Wan, Erqin Zhang, Yongkun Du

Published in

Veterinary microbiology. Volume 323. Pages 111285. Nov 08, 2026. Epub Nov 08, 2026.

Abstract

Porcine reproductive and respiratory syndrome (PRRS), caused by PRRS virus (PRRSV), is a highly contagious swine disease characterized by reproductive failure in sows and respiratory illness in pigs of all ages, especially piglets, and poses a significant threat to the global swine industry. The high mutation rate of PRRSV limits the protective efficacy of existing vaccines. Glucose-regulated protein 94 (Grp94), also known as gp96 or Hsp90B1, is an endoplasmic reticulum (ER) chaperone of the HSP90 family that interacts with diverse viral proteins and plays key roles in immune regulation. Previous studies from our laboratory revealed elevated gp96 expression in the lung tissues of PRRSV-infected pigs. In this study, gp96 overexpression dose-dependently inhibited PRRSV replication across the tested viral strains, whereas gp96 knockdown or pharmacological inhibition promoted viral replication. Domain analysis suggested that the C-terminal domain is important for the antiviral function of gp96. Stage-of-infection assays further showed that gp96 mainly suppressed the replication and assembly stages of the PRRSV life cycle, with little effect on viral attachment, entry, or release. Mechanistically, gp96-mediated antiviral activity was associated with IRF3 phosphorylation, IFN-β upregulation, and suppression of NF-κB phosphorylation. The TBK1/IKKε inhibitor BX795 and the NF-κB activator PMA attenuated the antiviral effect of gp96, whereas the NF-κB inhibitor BAY 11-7821 suppressed PRRSV replication. Together, these findings provide evidence that gp96 inhibits replication of the tested PRRSV strains, offer new insights into host antiviral mechanisms, and lay a theoretical foundation for the development of antiviral strategies or novel vaccine adjuvants against PRRSV.

PMID:
43033736
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement